U.S. flag

An official website of the United States government

GTR Home > Tests > Fibrillinopathy NGS panel

Performance Characteristics

Availability

Help

  • Entire test performed in-house
  • If applicable, Maternal Cell Contamination testing is performed by an outside CLIA-approved university laboratory.

Analytical Validity

Help

Sensitivity and Specificity >99%

Citations

Not provided

Proficiency Testing (PT)

Is proficiency testing performed for this test? Help
Yes
Method used for proficiency testingHelp
Intra-Laboratory
PT ProviderHelp
Other
PT Description
Internal proficiency testing is conducted biannually in compliance with all CAP regulations. Inter-laboratory proficiency testing is performed for some tests.

FDA Regulatory Clearances of the Test

Help
FDA Category Designation
Not Applicable

Practice guidelines

  • ACMG ACT, 2021
    American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Methionine +/- Elevated Homocysteine, Homocystinuria (Cystathionine beta-synthase deficiency), 2021
  • ACMG Algorithm, 2021
    American College of Medical Genetics and Genomics, Algorithm, Elevated Methionine +/- Elevated Homocysteine, 2021
  • ACMG ACT, 2012
    American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Homocystinuria (CBS Deficiency), 2012

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.